EXANE DERIVATIVES: AGG position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on AGG, newest first. How the timeline and the estimate are built.
EXANE DERIVATIVES held 44,298 AGG shares at 2022-06-30 per its 13F-HR filed 2022-07-12.
the latest 13F is the newest step
- period ended2022-06-3013F 44,298 sharesChange vs previous 13F not available
2.59% of the 13F portfolio, value $4,503,302.
13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec ยง4.2).